Oxygen Therapy Market Business Opportunties and Growth 2018 to 2026
Oxygen therapy is
the use of oxygen as medical intervention to maintain enough oxygen
in conditions such as hypoxia, hypoxemia, and other related
conditions. Oxygen may be administered through a nasal cannula, face
mask, or through hyperbaric oxygen chamber. This therapy helps
maintain oxygen level in the blood for treatment of acute and chronic
diseases such as chronic obstructive diseases (COPD), pneumonia, and
asthma. Long-term therapy with oxygen is often useful in people
suffering from COPD. Certain other acute or chronic disease
conditions where oxygen therapy is effective include cystic fibrosis,
dysplasia, heart failure, sleep apnea, and lung disorders.
Request
Sample Copy Of This Business
Report:
Oxygen therapy
market taxonomy
The global oxygen
therapy market is segmented on basis of source equipment,
application, delivery device, and end use. By type of source
equipment, the market in oxygen therapy is segmented into oxygen
cylinders, liquid oxygen devices, and oxygen concentrators. On the
basis of device type, the the oxygen therapy industry is segmented
into nasal cannula, face mask, bag valve mask, venturi mask, oxygen
mask, non-rebreather mask, and CPAP devices. On the basis of
application, the global oxygen therapy market is as asthma, cystic
fibrosis, COPD, pneumonia, respiratory distress syndrome, and
cardiovascular diseases.
Oxygen therapy is
used in hospitals to cure patients suffering from respiratory
diseases such as COPD and pneumonia, and also cardiovascular diseases
fueling growth of the oxygen therapy market. Oxygen therapy is also
used in clinics, rehabilitations centers and home care settings .
Increasing
incidence of COPD and lung disorders drive growth of the oxygen
therapy market across the globe
Factors such as high
prevalence of respiratory related diseases, growing aging population,
and increasing vulnerability of the populace to respiratory
conditions are fueling growth of the oxygen therapy market in North
America. According to the Center for Diseases Control and Prevention
(CDC), around 15.7 million people in the U.S. were diagnosed with
COPD in 2013. Other factors driving demand for oxygen therapy include
innovation in portable oxygen concentrators, rise in number of
untreated sleep apnea cases, favorable reimbursement scenario,
growing demand for oxygen filling devices, good medical facilities,
and high investment in research and development activities. The
European market in oxygen therapy is also gaining traction in recent
times, mainly fueled by increasing number of patients suffering from
respiratory diseases and favorable government initiatives to
facilitate respiratory care.
According to the
World Health Organization, over 90% of COPD deaths occur in low
income and middle income countries. Therefore, the oxygen therapy
market is expected to grow substantially in African, Asian, and Latin
American countries due to high prevalence of COPD and deaths due to
the disease. Furthermore, increasing awareness among medical
facilities, increasing government investment in healthcare
facilities, and availability of low cost treatment is projected to
drive demand for oxygen therapy in emerging economies.
Alarming increase
in number of lung damage cases increasing demand for oxygen therapy
for effective treatment
According to World
Health Organization (WHO) over 3 million people die each year due to
COPD. Increasing use of oxygen therapy in treatment of diseases such
as COPD, asthma, obstructive sleep apnea, and respiratory distress
syndrome is a supportive prevalent trend in the market. Long-term
oxygen therapy for patients suffering from chronic lung disease can
help improve quality and length of life, in turn creating a favorable
environment for the market. Increasing risk of lung damage due to
tobacco consumption, occupational hazards, and pollution would
further augment market growth over the following decade.
Download the
PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/97
Global players
engaged in the oxygen therapy market
There are several
medical device companies, both local player and global ones, engaged
in manufacture of oxygen therapy devices. Some of the prominent
players are Respironics, Inc. (a Philips company), Fisher &
Paykel Healthcare Limited, Teleflex Incorporated, Invacare
Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss
Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc. Click
To Reading More On
Comments
Post a Comment